Paul S. Appelbaum, MD

Expertise in: 
General Psychiatry / Psychology, Depression, Anxiety Disorders
Board Certifications: 
Psychiatry, Forensic Psychiatry
Accepting New Patients
Profile Hero

Overview

Areas of Expertise / Conditions Treated

Depression, Anxiety Disorders, General Psychiatry / Psychology, Psychiatry, Adjustment Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Bipolar Disorder, Insomnia, Mental Health, Mood Disorders, Obsessive Compulsive Disorder (OCD), Panic Disorder, Psychopharmacology, Psychosis, Psychotherapy

Academic Appointments

  • Elizabeth K. Dollard Professor

Administrative Titles

  • Director, Division of Law, Ethics & Psychiatry, Department of Psychiatry

I have a general psychiatric practice, with a particular emphasis on depression, anxiety, and adjustment disorders. My patients receive psychotherapy and/or medications, according to their needs and preferences.

Paul S. Appelbaum, M.D., the Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law, and Director, Division of Law, Ethics and Psychiatry at Columbia, was previously A.F. Zeleznik Distinguished Professor and Chairman, Department of Psychiatry; and Director, Law and Psychiatry Program, University of Massachusetts Medical School.

Dr. Appelbaum is the author of many articles and books on law and ethics in clinical practice. Dr. Appelbaum is Past President of the American Psychiatric Association, the American Academy of Psychiatry and the Law, and the Massachusetts Psychiatric Society, and has twice served as Chair of the Council on Psychiatry and Law and of the Committee on Judicial Action for the American Psychiatric Association (APA). Dr. Appelbaum is currently Chair of the DSM Steering Committee for APA, and of the Standing Committee on Ethics of the World Psychiatric Association. He has received the Isaac Ray Award of the American Psychiatric Association for "outstanding contributions to forensic psychiatry and the psychiatric aspects of jurisprudence," was the Fritz Redlich Fellow at the Center for Advanced Study in the Behavioral Sciences, and has been elected to the Institute of Medicine of the National Academy of Sciences. Dr. Appelbaum performs forensic evaluations in civil and criminal cases, and treats patients with a broad variety of problems, including depression, anxiety, and adjustment problems.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
646-774-8630

Location(s)

CUMC/Herbert Pardes Building of the New York State Psychiatric Institute
1051 Riverside Drive
New York, NY 10032
Primary

Credentials & Experience

Education & Training

  • Harvard Medical School
  • Internship: Soroka Medical Center, Beersheva, Israel
  • Residency: Massachusetts Mental Health Center

Board Certifications

  • Psychiatry
  • Forensic Psychiatry

Honors & Awards

  • 2013:  Golden Apple Award for significant contributions to forensic psychiatry, American Academy of Psychiatry and Law
  • 2012:  Distinguished Life Fellow, American Psychiatric Association
  • 2008:  America’s Top Doctors (and every year since)
  • 2007:  Best Doctors in America (and every year since)
  • 2007:  Isaac Hays, MD and John Bell, MD Award for leadership in medical ethics and professionalism, American Medical Association
  • 2001:  C. Charles Burlingame Award for major contributions to the field of psychiatry, Institute of Living
  • 2000:  Elected to membership in the Institute of Medicine of the National Academy of Sciences
  • 1997:  Edward J. Strecker, M.D. Award for outstanding contributions in clinical psychiatry, Institute of the Pennsylvania Hospital
  • 1996-1997:  Fritz Redlich Fellow, Center for Advanced Study in the Behavioral Sciences
  • 1990:  Isaac Ray Award for outstanding contributions to forensic psychiatry and the psychiatric aspects of jurisprudence, American Psychiatric Association
America's Top Doctor

Research

Dr. Appelbaum's research focuses on how legal and ethical rules affect medical practice and research, including informed consent, decisional capacity, mandatory treatment, advance directives, and confidentiality. He has a special interest in ethical and legal implications of neuropsychiatric genetics.

Dr. Appelbaum is involved in funded projects examining: functioning of IRBs at major medical centers around the country; therapeutic misconception in consent to research; use of behavioral genetic data in the courts; the consequences of returning genomic data to research subjects; unrealistic optimism in consent to medical research; use of N-of-1 trials; and impact of genetic conceptualizations of illness in Africa. He leads a NHGRI-funded center for research on ethical, legal, and social implications of psychiatric, neurologic and behavioral genetics.

Research Interests

  • See description above.
  • General Adult Psychiatry (psychotherapy and psychopharmacology)

Grants

2006-2016 Co-Investigator and Director of Ethics Resource, Clinical and Translational Science Award, NCATS UL1TR000040 (Henry Ginsberg, MD, Principal Investigator).
2012-2017 Co-Investigator, Understanding Therapeutic Optimism and its Impact on Risk-Benefit Assessment, NCI 1R01CA166556-01A1 (Lynn Jansen, PhD, PI).
2013-2018 Principal Investigator, Center for Research on the Ethical, Legal and Social Implications of Psychiatric, Neurologic and Behavioral Genetics, NHGRI 1P50HG007257.
2014-2016 Co-Investigator, Therapeutic Misconception and Scientific Reframing NCCAM 1R21AT008648-01, (Charles Lidz, PhD, PI).
2014-2019 Co-Investigator, Central IRBs: Enhanced Protections for Human Research Participants?, NIGMS 1R01GM113640-01, (Charles Lidz, PhD, PI).
2014-2017 Co-Investigator, Empowering Patients to Optimize their Selection of Blood Pressure Medications Using N-of-1 Trials, PCORI ME-1403-12304, (Karina Davidson, PhD, PI).
2015-2018 Co-Investigator, Stigma in African Genomics Research on Schizophrenia and Rheumatic Heart Disease, NHGRI 1U01HG008226-01, (Jantina DeVries, PhD, PI).

ELSI BIENNIAL CONGRESS (Federal Gov)

Jul 15 2019 - Jun 30 2024

NEW YORK STATE PSYCHIATRIC INSTITUTES FORENSIC (NY State Gov)

Jul 1 2018 - Jun 30 2023

NEW YORK CITY CONSORTIUM FOR PRECISION MEDICINE (Federal Gov)

Mar 24 2018 - Feb 28 2023

DEVELOPMENT OF RECOMMENDATIONS AND POLICIES FOR GENETIC VARIANT RECLASSIFICATION (Federal Gov)

Sep 24 2018 - Jun 30 2022

CENTER FOR RESEARCH ON ETHICAL, LEGAL & SOCIAL IMPLICATIONS OF PSYCHIATRIC, NEUROLOGIC & BEHAVIORAL GENETICS (Federal Gov)

Sep 17 2018 - Jun 30 2022

KIDNEY PRECISION MEDICINE PROGRAM (KPMP): COLUMBIA AKI RECRUITMENTSITE (Federal Gov)

Sep 15 2017 - Jun 30 2022

RE-ENGINEERING PRECISION THERAPEUTICS THROUGH N-OF-1 TRIALS (Federal Gov)

Sep 1 2017 - May 31 2022

THE NEUROBIOLOGY OF VIOLENCE IN A PSYCHOSIS-RISK COHORT (Federal Gov)

Sep 1 2017 - May 31 2022

COLUMBIA/CORNELL/HARLEM HOSPITAL PRECISION MEDICINE INITIATIVE HPO (Federal Gov)

Jul 6 2016 - Dec 31 2021

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Jul 1 2016 - May 31 2021

WRESTLING WITH SOCIAL/BEHAVIORAL GENOMICS: RISKS, POTENTIAL BENEFITS, AND ETHICAL RESPONSIBILITY (Private)

Jul 1 2019 - Jun 30 2020

COLUMBIA GENIE (GENOMIC INTEGRATION WITH EHR) (Federal Gov)

Sep 1 2015 - Mar 31 2020

GENETICS, EPIGENETICS, PHILOSOPHY AND COMPLEX BEHAVIOR (Private)

Sep 1 2016 - Dec 31 2019

ENGAGING STAKEHOLDERS IN BUILDING PATIENT-CENTERED N-OF-1 RANDOMIZED AND OTHER CONTROLLED TRIAL METHODS (Private)

Dec 1 2014 - Mar 31 2019

CENTRAL IRBS: ENHANCED PROTECTIONS FOR HUMAN RESEARCH PARTICIPANTS? (Federal Gov)

Sep 25 2014 - Aug 31 2018

ENGAGING STAKEHOLDERS IN BUILDING PATIENT-CENTERED N-OF-1 RANDOMIZED AND OTHER CONTROLLED TRIAL METHODS (Private)

Dec 1 2014 - Jun 30 2018

ENGAGING STAKEHOLDERS IN BUILDING PATIENT-CENTERED N-OF-1 RANDOMIZED AND OTHER CONTROLLED TRIAL METHODS (Private)

Dec 1 2014 - Nov 30 2017

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UL1) (Federal Gov)

Sep 30 2006 - Jun 30 2016

THE GOALS AND PRACTICES FOR NEXT GENERATION PRENATAL TESTING (Federal Gov)

Aug 10 2015 - May 31 2016

COLUMBIA CENTER FOR THE HEALTH OF URBAN MINORITIES (Federal Gov)

Feb 10 2003 - Jan 31 2016

IMPACT OF RETURN OF INCIDENTAL GENETIC TEST RESULTS TO RESEARCH PARTICIPANTS IN THE GENOMIC ERA (Federal Gov)

Sep 23 2011 - Aug 31 2015

NEW YORK STATE OFFICE OF MENTAL HEALTH FELLOWSHIP PROGRAM IN GERIATRIC PSYCHIATRY (NY State Gov)

Jul 1 2013 - Jun 30 2015

CHALLENGES OF INFORMED CONSENT IN RETURN OF DATA FROM GENOMIC RESEARCH (Federal Gov)

Sep 23 2011 - Aug 31 2014

IMPACT OF RETURN OF INCIDENTAL GENETIC TEST RESULTS TO RESEARCH PARTICIPANTS IN THE GENOMIC ERA (Federal Gov)

Sep 23 2011 - Aug 31 2014

CENTER FOR ELSI RESEARCH ON PSYCHIATRIC, NEUROLOGIC, AND BEHAVIORAL GENETICS (Federal Gov)

Jun 1 2010 - Apr 30 2014

NYSPI FORENSIC PSYCHIATRY CONTRACT (NY State Gov)

Jul 1 2008 - Jun 30 2013

UNDERSTANDING OPTIMISM IN CLINICAL RESEARCH (Federal Gov)

Jul 1 2012 - Apr 30 2013

PROXY DECISION MAKING FOR ALZHEIMER DISEASE RESEARCH (Federal Gov)

Sep 1 2007 - Jun 30 2012

FIREARM LAWS, MENTAL DISORDER, AND VIOLENCE (Private)

Mar 31 2011 - May 31 2012

CAPACITY OF CHILDREN AND TEENS TO DECIDE ABOUT CANCER (Federal Gov)

May 1 2009 - Mar 31 2012

THE BLURRING OF TREATMENT AND RESEARCH IN CLINICAL TRIALS: TWO PROBLEMS (Federal Gov)

Sep 28 2009 - Feb 29 2012

EXAMING ETHICAL ISSUES IN RESEARCH ON DEEP BRAIN STIMULATION (Private)

Jul 1 2008 - Jun 30 2011

ETHICS OF SURROGATE CONSENT FOR DEMENTIA RESEARCH (Federal Gov)

Sep 15 2007 - Jun 30 2011

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UL1) (Federal Gov)

Sep 30 2006 - Jun 30 2011

AN OBSERVATIONAL DESCRIPTIVE STUDY OF IRB PRACTICES (Federal Gov)

Jun 1 2006 - Apr 30 2011

MODIFIABLE RISK AND PROTECTIVE FACTORS FOR SUICIDAL BEHAVIOR S IN THE US ARMY - SUPPLEMENT (Federal Gov)

Sep 30 2009 - Apr 7 2011

MODIFIABLE RISK AND PROTECTIVE FACTORS FOR SUICIDAL BEHAVIORS IN THE U.S. ARMY (Federal Gov)

Jul 16 2009 - Apr 7 2011

RESEARCH ETHICS IN SCHIZOPHRENIA (Federal Gov)

Jun 1 2006 - May 31 2009

Selected Publications

  • Appelbaum PS, Gutheil TG: Clinical Handbook of Psychiatry and the Law, 4th ed, Lippincott/Williams & Wilkins, Philadelphia, PA, USA, 2007
  • Berg JW, Appelbaum PS, Lidz CW, Parker L: Informed Consent: Legal Theory and Clinical Practice, 2nd ed, Oxford University Press, New York, NY, USA, 2001
  • Grisso T, Appelbaum PS: Assessing Competence To Consent To Treatment: A Guide for Physicians and Other Health Professionals. 1998
  • Appelbaum PS: Almost a Revolution: Mental Health Law and the Limits of Change. 1994
  • Anfang SA, Appelbaum PS : Forensic evaluation of the older patient, in Agronin ME, Maletta GJ (eds.), Principles and Practice of Geriatric Psychiatry, 2nd ed. Philadelphia, Lippincott/Williams & Wilkins., Lippincott/Williams & Wilkins, Philadelphia,PA,USA, 2011
  • Klitzman R, Abbate KJ, Chung WK, Marder KS, Ottman R, Johansen Taber K, Leu C-S, Appelbaum PS. Psychiatrists' views of the genetic bases of mental disorders and behavioral traits and their utilization of genetic tests. Journal of Nervous and Mental Disease 2014; 202.530-538.